Diametric Capital’s OptimizeRx OPRX Stock Holding History

Diametric Capital’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,263	Closed	-$408K	–	553
2025 Q4	$408K	Buy	+33,263	New	+$544K	0.11%	270
2025 Q2	–	Sell	-13,298	Closed	-$115K	–	375
2025 Q1	$115K	Buy	+13,298	New	+$81.3K	0.14%	161
2024 Q4	–	Sell	-23,974	Closed	-$185K	–	420
2024 Q3	$185K	Buy	+23,974	New	+$213K	0.09%	314
2022 Q3	–	Sell	-24,214	Closed	-$663K	–	310
2022 Q2	$663K	Buy	+24,214	New	+$718K	0.49%	51

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diametric Capital's OPRX Position: Q1 2026 in Review

Diametric Capital sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 33,263 shares — an estimated $408K sold.

Diametric Capital first reported a position in OPRX in Q2 2022 and held it in 4 quarters. The position peaked at $663K in Q2 2022. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Diametric Capital reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
Diametric Capital sold 33,263 OptimizeRx shares in Q1 2026, an estimated $408K.
Diametric Capital first reported a position in OptimizeRx in Q2 2022 and held it in 4 quarters.
Diametric Capital's OptimizeRx position peaked at $663K in Q2 2022.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.